Bank of Montreal’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,400
Closed -$720K 4170
2022
Q4
$720K Hold
30,400
﹤0.01% 2384
2022
Q3
$807 Hold
30,400
﹤0.01% 2304
2022
Q2
$1.14K Sell
30,400
-6,600
-18% -$280K ﹤0.01% 2228
2022
Q1
$2.71M Buy
+37,000
New +$2.67M ﹤0.01% 1770
2020
Q3
Sell
-126,500
Closed -$28.9M 4928
2020
Q2
$28.9M Buy
+126,500
New +$22.2M 0.03% 472
2019
Q3
Sell
-20,000
Closed -$1.33M 4972
2019
Q2
$1.33M Hold
20,000
﹤0.01% 1931
2019
Q1
$1.11M Buy
+20,000
New +$1.22M ﹤0.01% 1981

Other funds holding TDOC

Bank of Montreal's TDOC Position: Q4 2024 in Review

Bank of Montreal sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 8,027 shares — an estimated $67.9K sold.

Bank of Montreal first reported a position in TDOC in Q1 2016 and held it in 35 quarters. The position peaked at $318M in Q4 2021. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Bank of Montreal reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 8,027 Teladoc Health shares in Q4 2024, an estimated $67.9K.
  • Bank of Montreal first reported a position in Teladoc Health in Q1 2016 and held it in 35 quarters.
  • Bank of Montreal's Teladoc Health position peaked at $318M in Q4 2021.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.